
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.
General Description:
The Application Integration Architect and Integration Center of Excellence (CoE) Lead is responsible for leading the strategy, design, and delivery of enterprise-wide application integrations across BeOne’s global IT landscape within Global Technology Services. This role focuses on API-based, event-driven, and cloud-native integration patterns to enable scalable, secure, and resilient data and process interoperability between internal systems and external partners.
As the technical leader for application integration, this role also establishes and leads the Integration Center of Excellence, defines integration architecture standards, governs API design and lifecycle management, and partners closely with business, data, security, and application teams to support digital transformation and enterprise modernization initiatives.
Essential Functions of the Job:
Qualifications:
Education Required: Bachelor’s degree in computer science, Information Systems, Engineering, or a related field. Master’s degree preferred.
Supervisory Responsibilities:
Global Competencies
When we exhibit our values of Patients First, Driving Excellence, Bold Ingenuity, and Collaborative Spirit, through our twelve global competencies below, we help get more affordable medicines to more patients around the world.
We are proud to be an equal opportunity employer. BeOne does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible.
To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.